Register Login

Iovance Biotherapeutics Inc (IOVA)

  • Event
  • June 13, 2022, 21:15 UTC

(75% Positive) IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Announces Enrollment Update for needs Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Oct. 2, 2025, 7:12 a.m.

    📋 IOVANCE BIOTHERAPEUTICS, INC. (IOVA) - Clinical Trial Update

    Filing Date: 2022-06-13

    Accepted: 2022-06-13 17:15:50

    Event Type: Clinical Trial Update

    Event Details:

    Iovance Biotherapeutics Inc (IOVA) Announces Clinical Trial Update Iovance Biotherapeutics Inc (IOVA) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: needs, experience
    • Collaboration: Board of Directors

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Iovance Biotherapeutics Inc
    • CIK: 0001425205
    • Ticker Symbol: IOVA
    • Period End Date: 2022-06-10
    • Document Type: 8-K

Search

News categories